Evidence map›Paper›PMID 39819775›Full record

ArticleBiofabrication2025

One-step bioprinting of endothelialized, self-supporting arterial and venous networks.

Betty Cai, David Kilian, Sadegh Ghorbani, Julien G Roth, Alexis J Seymour, Lucia G Brunel, Daniel Ramos Mejia, Ricardo J Rios, Isabella M Szabo, Sean Chryz Iranzo and 4 more

Abstract read
In one paragraph

Article in Biofabrication, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Betty CaiDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, United States of America.ORCID 0000-0002-2160-4167
David KilianDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, United States of America.ORCID 0000-0003-3151-3637
Sadegh GhorbaniDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, United States of America.ORCID 0000-0002-9591-7721
Julien G RothInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, United States of America.ORCID 0000-0002-7560-3258
Alexis J SeymourDepartment of Bioengineering, Stanford University, Stanford, CA 94305, United States of America.ORCID 0000-0002-8354-1325
Lucia G BrunelDepartment of Chemical Engineering, Stanford University, Stanford, CA 94305, United States of America.ORCID 0000-0003-0327-5635
Daniel Ramos MejiaDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, United States of America.ORCID 0009-0003-5374-3289
Ricardo J RiosDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, United States of America.
Isabella M SzaboDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, United States of America.
Sean Chryz IranzoDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, United States of America.ORCID 0009-0000-0439-0550
Andy PerezDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, United States of America.
Rameshwar R RaoBen Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA 98101, United States of America.ORCID 0000-0003-0136-2807
Sungchul ShinDepartment of Agriculture, Forestry, and Bioresources, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0001-6957-6428
Sarah C HeilshornDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, United States of America.ORCID 0000-0002-9801-6304

Funding

Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
Injectable Hydrogels to Deliver Gene Therapy for Myocardial InfarctR01HL151997 · NHLBI · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2020 to 2023
$1.7M
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cellsR01HL142718 · NHLBI · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C, HUANG, NGAN F. · 2018 to 2021
$1.6M
Injectable Hydrogels to Protect Transplanted Cells from HypoxiaR01EB027666 · NIBIB · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C, PLANT, GILES · 2019 to 2022
$1.4M
Engineered biomaterials to modulate cell-cell signaling for the robust expansion of stem cellsR01EB027171 · NIBIB · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2019 to 2022
$1.4M
3D bioprinting of regenerative, corneal cell-laden inks to treat corneal blindnessF31EY034785 · NEI · STANFORD UNIVERSITY · PI BRUNEL, LUCIA · 2023 to 2024
$82k
NEI NIH HHS F31 EY034785NHLBI NIH HHS R01 HL142718NHLBI NIH HHS R01 HL151997NIBIB NIH HHS R01 EB027171NIBIB NIH HHS R01 EB027666NICHD NIH HHS K12 HD000850
6 · The paper itself

Abstract

Advances in biofabrication have enabled the generation of freeform perfusable networks mimicking vasculature. However, key challenges remain in the effective endothelialization of these complex, vascular-like networks, including cell uniformity, seeding efficiency, and the ability to pattern multiple cell types. To overcome these challenges, we present an integrated fabrication and endothelialization strategy to directly generate branched, endothelial cell-lined networks using a diffusion-based, embedded 3D bioprinting process. In this strategy, a gelatin microparticle sacrificial ink delivering both cells and crosslinkers is extruded into a crosslinkable gel precursor support bath. A self-supporting, perfusable structure is formed by diffusion-induced crosslinking, after which the sacrificial ink is melted to allow cell release and adhesion to the printed lumen. This approach produces a uniform cell lining throughout networks with complex branching geometries, which are challenging to uniformly and efficiently endothelialize using conventional perfusion-based approaches. Furthermore, the biofabrication process enables high cell viability (>90%) and the formation of a confluent endothelial layer providing vascular-mimetic barrier function and shear stress response. Leveraging this strategy, we demonstrate for the first time the patterning of multiple endothelial cell types, including arterial and venous cells, within a single arterial-venous-like network. Altogether, this strategy enables the fabrication of multi-cellular engineered vasculature with enhanced geometric complexity and phenotypic heterogeneity.

Indexed as

ArteriesBioprintingVeinsCell SurvivalEndothelial CellsGelatinHumansHuman Umbilical Vein Endothelial CellsPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsGelatin3D bioprintingarterial–venous networksendothelializationvascular mimics

Identifiers

PMID39819775
PMCPMC12783891

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.